Selected Clinical Publications
- Alam, M and Yoo, SS. "Technique for calcium hydroxylapatite injection for correction of nasolabial fold depressions" Journal of the American Academy of Dermatology 2007; 56(2):285-289.
- Berlin, AL, Hussain, M, Goldberg, DJ. “Calcium Hydroxylapatite Filler for Facial Rejuvenation: A Histologic and Immunohistochemical Analysis. Dermatological Surgery 2008; 34:S64-67.
- Carruthers, A and Carruthers J, Liebeskind, M and Forster, B. “Radiographic and computed tomographic studies of calcium hydroxylapatite for treatment of HIV-associated facial Lipoatrophy and correction of nasolabial folds.” Dermatological Surgery 2008; 34:S78-84.
- Coleman, KM, Voigts, R, DeVore, DD, Termin, P and Coleman, WP III. “Neocollagenesis after injection of calcium hydroxylapatite composition in a canine model.” Dermatological Surgery 2008; 34: S53-S55.
- Comite, SL, Liu, JF, Balasubramanian, S and Christian, MA. “Treatment of HIV-associated facial lipoatrophy with Radiance FN™ (Radiesse™)” Dermatology Online Journal 2004;10(2):2. http://dermatology.cdlib.org/102/therapy/HIV/comite.html
- Eviatar JA, Silvers, SL and Echavez, MI. Restorative treatment of HIV-Associated Facial Lipoatrophy. Plastic and Reconstructive Surgery 2005. 116(Suppl).
- Marmur, ES, Phelps, R and Goldberg, DJ. “Clinical, histologic and electron microscopic findings after injection of a calcium hydroxylapatite filler” Journal of Cosmetic Laser Therapy 2004; 6:223-226.
- Moers-Carpi, M, Vogt, S, Santos, BM, Planas, J, Vallve, SR and Howell, DJ. “A multicenter, randomized trial comparing calcium hydroxylapatite to two hylauronic acids for treatment of nasolabial folds. Dermatologic Surgery 2007; 33:S144-S151.
- Moers-Carpi, M and Tufet JO. “Calcium hydroxylapatite versus stabilized hylauronic acid for the correction of nasolabial folds: a 12-month, multicenter, prospective, randomized, controlled, split-face trial. Dermatologic Surgery 2008; 34:210-215.
- Schweiger, ES, Riddle, CC, Wernli, BJ and Tonkovic-Capin, V. “Comparison of poly-l-lactic ccid and calcium hydroxylapatite for treating human Immunodeficiency virus-associated facial lipoatrophy.” Cosmetic Dermatology 2007. 20(5): 304-312.
- Silvers, SL, Eviatar, JA, Echavez, MI and Pappas, AL. “Prospective open label 18-month trial of calcium hydroxylapatite (Radiesse) for facial soft tissue augmentation in patients with HIV-associated lipoatrophy: One year durability” Plastic and Reconstructive Surgery Journal 2006; 118(3 Suppl):34S-45S.
- Smith, S, Busso, M, McClaren, M and Bass, LS. “A randomized, bilateral, prospective comparison of calcium hydroxylapatite microspheres versus human-based collagen for the correction of nasolabial folds. Dermatologic Surgery 2007; 33:S112-S121.